Hepatitis B virus infection among people attending the voluntary counselling and testing centre and anti-retroviral therapy clinic of St Paul's General Specialised Hospital, Addis Ababa, Ethiopia

Sexually Transmitted Infections

Volumn 84, Issue 1, 2008, Pages 37-41

  Shimelis, T ^a   Torben, W ^b   Medhin, G ^b   Tebeje, M ^c   Andualm, A ^d   Demessie, F ^e   Mulu, A ^f   Tegbaru, B ^c   Gebre Selassie, S ^g  

^a HAWASSA UNIVERSITY   (Ethiopia)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

^c ETHIOPIAN PUBLIC HEALTH INSTITUTE   (Ethiopia)

^d ST PAUL S HOSPITAL MILLENNIUM MEDICAL COLLEGE   (Ethiopia)

^e JIMMA UNIVERSITY   (Ethiopia)

^f UNIVERSITY OF GONDAR   (Ethiopia)

^g ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; ETHIOPIA; FEMALE; GENERAL HOSPITAL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; ANTI-RETROVIRAL AGENTS; COUNSELING; CROSS-SECTIONAL STUDIES; ETHIOPIA; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RURAL HEALTH; URBAN HEALTH;

EID: 38849182268     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2007.027326     Document Type: Article

References (25)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11:97-101.
2. Juszozyk J. Clinical course and consequence of hepatitis B infection. Vaccine 2000;18:S23-5.
3. Burnett RJ, Francois G, Kew MC, et al. Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation. Liver Int 2005;25:201-24.
4. Norman G. Hepatitis B: diagnosis, prevention, and treatment. Clin Chem 1997;43:1500-6.
5. Mahoney F. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev 1999;12:351-66.
6. Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006;44:S6-9.
7. Thimme R, Spangenberg H, Blum H. Hepatitis B or hepatitis C and human immunodeficiency virus infection. J Hepatol 2005;42:S37-44.
8. Gilson RJC, Hawkins AE, Beecham MR, et al. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS 1997;11:597-606.
9. Thio CL, Seaberg EC, Skolasky J, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the multicenter cohort study (MACS), Lancet 2002;360:1921-6.
10. Brook G. Prevention of viral hepatitis in HIV co-infection. J Hepatol 2006;44:S104-7.
11. Brinker MD, Wit FW, Dillan P, et al. Hepatitis B and C virus co-infection and the risk for hepatotoxicity of active antiretroviral therapy in HIV-1 infection. AIDS 2000;14:2895-902.
12. Manegold C, Hannoun C, Wywiol A, et al. Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy. Clin Infect Dis 2001;32:144-8.
13. Tesga E, Mengesha B, Hanson BG, et al. Hepatitis A, B, and Delta infection in Ethiopia: a serologic survey with demographic data. Am J Epidemiol 1986;123:345-51.
14. Abebe A, Nokes DJ, Dejene A, et al. Sero-epidemiology of hepatitis B in Addis Ababa, Ethiopia: transmission patterns and vaccine control. Epidemiol Infect 2003;131:757-70.
15. Duncan M, Tibaus G, Pelzer A, et al. Prevalence and significance of sexually transmitted diseases among women attending clinics in Addis Ababa. Ethiopian Journal of Health Development 1995;9:31-40.
16. Awole M, Gebre-Selassie S. Seroprevalence of HBsAg and its risk factors among pregnant women in Jimma, Southwest Ethiopia. Ethiopian Journal of Health Development 2005;19:45-50.
17. Rouet F, Chaix M, Inwoley A, et al. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d'Ivoire: the ANRS 1236 study. J Med Virol 2004;74:34-40.
18. Sutcliffe S, Taha TE, Kumwenda NI, et al. HIV-1 prevalence and herpes simplex virus 2, hepatitis C and hepatitis B virus infections among workers at a sugar estate in Malawi. J Aquir Immune Defic Syndr 2002;3:90-7.
19. Oshitanil H, Kasolo FC, Mpabalwaniz M, et al. Prevalence of hepatitis B antigens in human immunodeficiency virus type 1 seropositive and seronegative pregnant women in Zambia. Trans R Soc Trop Med Hyg 1996;90:235-6.
20. Simpore J, Savadogo A, Ilboudo D, et al. Toxoplasma gondii, HCV, and HBV seroprevalence and co-infection among HIV-positive and negative pregnant women in Burkina Faso. J Med Virol 2006;78:730-3.
21. Nakwagala FN, Kagimu MM. Hepatitis B and C infections, among patients in Mulago Hospital. East Afr Med J 2002;79:68-72.
22. Shao JF, Haukenes G, Yangi E, et al. Association of hepatitis B and human immunodeficiency virus infections in Tanzanian population groups. Eur J Clin Microbiol Infect Dis 1993;12:13-15.
23. Solomon RE, Van Raden M, Kaslow RA, et al. Association of hepatitis B surface antigen and core antibody with acquisition and manifestations of human immunodeficiency virus type 1 (HIV-1) infection. Am J Publ Health 1990;80:1475-8.
24. Rogers AS, Lindsey JC, Futterman DC, et al. Serologic examination of hepatitis B infection and immunization in HIV positive youth and associated risks. AIDS Patient Care STDS 2000;14:651-7.
25. Nunez M, Puoti M, Camino N, et al. Treatment of chronic hepatitis B in the human immunodeficiency virus infected patients: present and future. Clin Infect Dis 2003;37:1678-85.